Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 13, 2007

Fluorotechnics Fortifies Electrophoresis Business with Purchase of ETC Elektrophorese-Technik

  • To buttress its services and position in the electrophoresis market, Fluorotechnics plans to acquire ETC Elektrophorese-Technik in a stock-for-stock agreement.

    Fluorotechnics focuses on the development of fluorescent research tools for proteomics, cell biology, and biochemistry research. ETC Elektrophorese-Technik will add high-end electrophoresis consumables and equipment used for diagnostics, quality control, and species identification.

    The integrated company will retain its manufacturing bases in Sydney and Kirchentellinsfurt, Germany.

    “This acquisition will allow us to cross-sell products to existing customers and to address new markets utilizing our joint expertise,” remarks Duncan Veal, CEO of Fluorotechnics. The company’s expanding sales and marketing team, and the potential of its products, Veal adds, “means that we are well-positioned for strong growth.”



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »